Table 5 Impact of MDA on mf prevalence at the level of the implementation unit in four states/regions of Myanmar during 2001–2016
State/region | Name of IU | Baseline mf prevalence | No of MDAs | MDA compliance rate (range) | Mf prevalence (range) | No. of sites with mf prevalence | Filarial antigen prevalence | Decision about MDA status | |
|---|---|---|---|---|---|---|---|---|---|
< 1% | > = 1 | ||||||||
Magway | Magway | 4.1 | 13 | 92–96 | 0.0–7.1 | 5 | 6 | 2.4 | Continue |
Thayet | 7.1 | 13 | 93–96 | 0.0–6.3 | 5 | 5 | 3.6 | Continue | |
Pakoku | 9.2 | 13 | 92–96 | 0.0–9.2 | 4 | 5 | 3.8 | Continue | |
Minbu | 4.4 | 12 | 94–97 | 0.3–4.4 | 3 | 7 | 3.3 | Continue | |
Sagaing | Sagaing | 5 | 12 | 93–96 | 0.2–7 | 3 | 5 | 4.7 | Continue |
Monywa | 5 | 12 | 92–96 | 0.0–5.5 | 4 | 4 | 3.8 | Continue | |
Shwebo | 8 | 12 | 93–95 | 0.0–15.1 | 2 | 11 | 6.8 | Continue | |
Mandalay | Nyaung U | 8 | 94–97 | 0.4–1.3 | 2 | 1 | 0.8 | Continue | |
Yamethin | 4.5 | 8 | 93–97 | 0.2–6.0 | 2 | 4 | 2.4 | Continue | |
Meikhtila | 4 | 8 | 92–95 | 0.2–7.2 | 2 | 4 | 2.6 | Continue | |
Mandalay | 4.5 | 8 | 91–96 | 0.2–8.8 | 3 | 3 | 3 | Continue | |
Kyauk Se | 8 | 94–96 | 1.5–3.7 | 0 | 3 | 2.4 | Continue | ||
Myingyan | 8 | 8 | 93–97 | 1.3–13.3 | 0 | 6 | 3.2 | Continue | |
Pyin Oo Lwin | 0.3 | 8 | 92–97 | 0.0–0.4 | 5 | 0 | 0.5 | Stop | |
Rakhine | Sittwe | 7 | 6 | 92–96 | 0.0- 12.6 | 3 | 3 | 1 | Stop |
Maungtaw | 1 | 6 | 93–96 | 0.0–1.6 | 5 | 1 | 0.8 | Stop | |
Kyaukphyu | 1 | 6 | 94–97 | 0.0–2.34 | 3 | 2 | 1 | Stop | |
Thandwe | 0 | 6 | 95–96 | 0–0 | 4 | 0 | 0 | Stop | |